Search
for
Sort by
Research 361–390 of 1000+
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- Associations among hair loss, oral sulfur-containing gases, and gastrointestinal and metabolic linked diseases in Japanese elderly men: pilot study
- Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
- Androgenetic alopecia and COVID‐19: Is there a clinical connection?
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Microneedling and Its Use in Hair Loss Disorders: A Systematic Review
- Association of Baldness with Coronary Artery Disease and Its Severity
- Local Pharmacokinetics and Tolerability of Topically‐Applied Bimatoprost to the Scalp of Male Patients With Androgenetic Alopecia
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- A RANDOMIZED, PROSPECTIVE, SINGLE-BLIND CLINICAL TRIAL: COMPARATIVE STUDY OF COMPARING THE EFFICACY AND SAFETY OF DIFFERENT MINOXIDIL FORMULATIONS IN TREATING ANDROGENIC ALOPECIA
- Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early‐Onset Androgenetic Alopecia: A Case–Control Study
- Molecular and cellular mechanisms of natural cosmetics and medical treatment in skin-antiaging: A review article
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- Association Between Smoking and Androgenetic Alopecia: A Cross-Sectional Analysis of Severity and Dose-Response Relationship in Adult Males
- Correlation of Trichoscopic Findings with Severity in Androgenetic Alopecia
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- Androphenotypic features in patients with coronary artery disease
- Genetic Basis of Male Pattern Baldness
- Association of Hypertension and Serum Aldosterone Levels in Male Patients with Androgenetic Alopecia: A Case-Control Study
- Tissue engineering; strategies, tissues, and biomaterials
- Genetic Analysis of Male Pattern Baldness and the 5α-Reductase Genes
- Fibroblast state switching orchestrates dermal maturation and wound healing
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Gata6 promotes hair follicle progenitor cell renewal by genome maintenance during proliferation
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Ethnobotanical Survey of Natural Galactagogues Prescribed in Traditional Chinese Medicine Pharmacies in Taiwan
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia